Tue, Oct 21, 2014, 7:01 AM EDT - U.S. Markets open in 2 hrs 29 mins

Recent

% | $
Quotes you view appear here for quick access.

QUALCOMM Incorporated Message Board

nameofthegame777 6 posts  |  Last Activity: Sep 10, 2014 5:42 PM Member since: Apr 13, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Part 1

    From the Wall Street Journal - Japan
    8:39 pm JST
    Apr 28, 2014

    Japanese Nobel Winner Latest to Apologize Over Stem-Cell Research

    A scandal involving Japanese stem-cell research took a surprising turn Monday when the nation’s most revered researcher in the field, Nobel Prize laureate Shinya Yamanaka, apologized for what he described as poor record-keeping.

    The apology came after months of soul-searching in Japan over research ethics. A researcher at the prestigious Riken institute, Haruko Obokata, apologized earlier this month after admitting errors in a paper in the journal Nature that described a possible new method of creating stem cells.

    Last week, the head of the Riken panel investigating Dr. Obokata had to resign from the panel after admitting that a paper he co-authored used some of the same improper methods of cutting and pasting images that he had criticized in Dr. Obokata’s work.

    On Monday evening, Dr. Yamanaka, a professor at Kyoto University, spoke at a news conference after questions arose about an image in a 2000 paper on which he was the lead author. In the paper, Dr. Yamanaka, then at Nara University, described a protein that played a role in turning embryo cells into cells specific to a part of the body.

    The university said it conducted an investigation after Dr. Yamanaka informed administrators about allegations he discovered online that an image in the paper was doctored. It didn’t identify the party raising the allegations.
    Kyoto University said it found no problem with the paper’s conclusions, but Dr. Yamanaka acknowledged that he no longer had the lab records that would support the validity of the images.

    “I would like to express remorse from my heart and apologize,” he said.

  • Reply to

    Clear headed thinking by management

    by nameofthegame777 Aug 27, 2014 6:52 PM
    nameofthegame777 nameofthegame777 Aug 27, 2014 10:36 PM Flag

    jnichols_9627111 "Wow 6 posts since 2011... I hear you....and thanks for the wisdom...Thump up...."

    I used to post periodically on Yahoo until the format change.
    You can go to stocktwits under nameofthegame7. Archive my posts.
    I don't post they any more, I was just trying to help a few investors
    try and make back some of the money they previously lost. Nothing to prove here.
    I will not be responding to anymore of your posts. Have a nice evening

  • nameofthegame777 by nameofthegame777 Aug 27, 2014 6:52 PM Flag

    I don't post much. I have personally been involved in many a turn around plays of public stocks at the absolute bottom in price. ACTC is beginning to act like all great turn around stories do. They have a corporate road map, and now they have a highly regarded CEO. If as an investor you have been successful in buying turn story stocks at the bottom you should be happy if you bought Advanced Cell Tech between .06 - .07 recently. Clear headed thinking by management to do what needed to be done before not after the highly anticipated peer review report is released as the company has increased the ability of biotech funds and funds in general by several 100s of percent that will be able to buy ACTC stock and most importantly the stock is now margin-able.

  • Reply to

    This is CEO Dr. Wotton public address

    by nameofthegame777 Aug 8, 2014 4:53 PM
    nameofthegame777 nameofthegame777 Aug 8, 2014 6:30 PM Flag

    What are you talking about. IF the stock falls down to the .06 level I would be willing to buy some more shares. I already have a full position, so if it did drop to .06 it would be willing to buy a 4th wave. Don't try and imply what my motives are other than what I've stated, period

  • Reply to

    This is CEO Dr. Wotton public address

    by nameofthegame777 Aug 8, 2014 4:53 PM
    nameofthegame777 nameofthegame777 Aug 8, 2014 5:38 PM Flag

    A final point, I have accumulated a very nice position between .06 - .062 If the market is willing to sell me more shares at that .06 buy point again, I will be there to complete my 4th and final wave, call it a bonus wave of buying. I do this professionally for a living and I'M VERY GOOD AT WHAT I DO.

  • nameofthegame777 by nameofthegame777 Aug 8, 2014 4:53 PM Flag

    The conference call is a chance for the new CEO to position the company going forward, with any new leadership comes the mission statement moving forward. In order for shareholders of any publicly traded company to benefit long term from positive developments at a company you have to believe in the management team. If you asking why...it's all about the cost of financing dollars. The more confidence the higher the stock price the less dilution which doesn't negatively effect the cap base This is CEO Dr. Wotton public address to current and the very real potential of large shareholders going forward. Do I expect Dr. Wotton to leave investors with upbeat message, of course, why else did he come hear AT THS TME, surely not for the salary, that hardly jet sets you and the family to the Hampton's for more than a weekend or so. As we all know its stock and warrants he's received at very attractive prices, especially, when one considers the time consuming issues of previous managements indiscretions have been resolved

QCOM
73.27+0.84(+1.16%)Oct 20 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.